53 Performance of a trigger tool for detecting adverse drug reactions 15. Singh R, McLean-Plunckett EA, Kee R, Wisniewski A, Cadzow R, Okazaki S, et al. Experience with a trigger tool for identifying adverse drug events among older adults in ambulatory primary care. Qual Saf Heal Care 2009;18:199–204. https://doi.org/10.1136/ qshc.2007.024406. 16. Dutch Society for Geriatric Medicine. Multidisciplinary Guideline for Polpharmacy in older people. Addendum: polypharmacy optimisation in hospitalised older people. 2017:1–166. https://richtlijnendatabase.nl/richtlijn/polyfarmacie_bij_ouderen/ polyfarmacie_bij_ouderen_2e_lijn.html (last accessed: 16-03-2022) 17. Warlé-van Herwaarden MF, Valkhoff VE, Herings RMC, Engelkes M, Van Blijderveen JC, Rodenburg EM, et al. Quick assessment of drug-related admissions over time (QUADRAT study). Pharmacoepidemiol Drug Saf 2015. https://doi.org/10.1002/pds.3747. 18. Warlé-van Herwaarden MF, Kramers C, Sturkenboom MC, van den Bemt PMLA, De Smet PAGM. Targeting Outpatient Drug Safety. Drug Saf 2012;35:245–59. https://doi. org/10.2165/11596000-000000000-00000. 19. Shaw FE, Kenny RA. The overlap between syncope and falls in the elderly. Postgrad Med J 1997. https://doi.org/10.1136/pgmj.73.864.635. 20. Agbabiaka T, Savovic J, Ernst E. Methods for causality assessment. Drug Saf 2008;31:21–37. 21. Center WHO-TUM. WHOCausality assessment. Good Pharmacovigil Pract Guid 2009:39. 22. Thevelin S, Spinewine A, Beuscart JB, Boland B, Marien S, Vaillant F, et al. Development of a standardized chart review method to identify drug-related hospital admissions in older people. Br J Clin Pharmacol 2018. https://doi.org/10.1111/bcp.13716. 23. Landis JR, Koch GG. The Measurement of Observer Agreement for Categorical Data. Biometrics 1977. https://doi.org/10.2307/2529310. 24. Zerah L, Henrard S, Thevelin S, Feller M, Meyer-masseti C, Knol W, et al. Performance of a trigger tool for detecting drug-related hospital admissions in older people : analysis from the OPERAM trial 2021;716:1–13. 25. Marseau F, Prud’Homm J, Bouzillé G, Polard E, Oger E, Somme D, et al. The Trigger Tool Method for Routine Pharmacovigilance. J Patient Saf 2021;Publish Ah:1–8. https://doi. org/10.1097/pts.0000000000000820. 26. O’mahony D, O’sullivan D, Byrne S, O’connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: Version 2. Age Ageing 2015;44:213–8. https://doi.org/10.1093/ageing/afu145. 27. Seppala LJ, Petrovic M, Ryg J, Bahat G, Topinkova E, Szczerbinska K, et al. STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs. Age Ageing 2021;50:1189–99. https://doi.org/10.1093/ageing/afaa249. 28. Damoiseaux-Volman BA, Raven K, Sent D, Medlock S, Romijn JA, Abu-Hanna A, et al. Potentially inappropriate medications and their effect on falls during hospital admission. Age Ageing 2022;51:1–8. https://doi.org/10.1093/ageing/afab205. 29. Meyer-Massetti C, Cheng CM, Schwappach DLB, Paulsen L, Ide B, Meier CR, et al. Systematic review of medication safety assessment methods. Am J Heal Pharm 2011;68:227–40. https://doi.org/10.2146/ajhp100019. 30. Egger T, Dormann H, Ahne G, Runge U, Neubert A, Criegee-Rieck M, et al. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs and Aging 2003;20:769–76. https://doi.org/10.2165/00002512-200320100-00005. 31. Dormann H, Muth-Selbach U, Krebs S, Criegee-Rieck M, Tegeder I, Thomas Schneider H, et al. Incidence and costs of adverse drug reactions during hospitalisation. Computerised monitoring versus stimulated spontaneous reporting. Drug Saf 2000. https://doi.org/10.2165/00002018-200022020-00007. 2
RkJQdWJsaXNoZXIy MTk4NDMw